🇺🇸 FDA
Patent

US 8722863

Solid state forms of fidaxomycin and processes for preparation thereof

granted A61KA61K31/7048

Quick answer

US patent 8722863 (Solid state forms of fidaxomycin and processes for preparation thereof) held by Teva Pharmaceutical Works Ltd. expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Pharmaceutical Works Ltd.
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/7048